Spyre Therapeutics clinical trials we track

Check company identity source

Phase 2 4 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: To assess the safety and tolerability of study drug treatment regimens. After: Measure: Percentage of participants who experienced an adverse event.

Check registry source